Mark Cuban attacks healthcare through pricing transparency and market discipline. I would attack it through patient infrastructure, legal protection, accountability, and civic power. Together, those strategies could finally begin realigning the incentives driving American healthcare.

For 20 years, chemical reform promised protection. The system still allows widespread exposure while shifting risk to patients. This analysis explains how incentives, not science, determine what ends up in the products people use every day.

Millions cycle through eczema treatments that calm symptoms but never fix the cause. This essay explains how payment models, regulation, and product marketing keep patients trapped in repeat care instead of long term prevention.